,,,hummmm,,,a question for the scientific minds here on the board,,,BearDA in mind, :o) ,,,,the follow up trials with 208 on CKD, Fabry, etc,,,,,so why would safety and tolerability continue to be front and center after coming thru the BoM trial,,especially if BoM is a successful trial with no issues in the above parameters?,,,,,wouldnt the BoM trial prove that the two are/is a mute point?.....just thinking here.